Skip to main content
. Author manuscript; available in PMC: 2022 Apr 11.
Published in final edited form as: Eur Urol. 2020 Apr 13;78(1):63–74. doi: 10.1016/j.eururo.2020.03.003

Table 3.

Summary of LINC01187 expression in the validation cohort.

Primary Tumors Metastatic Tumors
Positive Cases Average H-Score Positive Cases Average H-Score
Classic ChRCC 34/34 (100%) 371.2 18/18 (100%) 367.8
Sarcomatoid ChRCC (spindled cells) 0/3 (0%) 0 0/1 (0%) 0
Eosinophilic ChRCC 6/8 (75%) 254.0 0 N/A
Hybrid oncocytic tumor (HOT) 7/7 (100%) 307.3 0 N/A
RCC, unclassified (oncocytic) 6/6 (100%) 346.0 0 N/A
Oncocytoma 18/18 (100%) 386.7 0 N/A
Clear Cell RCC 0/10 (0%) 0 0/15 (0%) 0
Papillary RCC 0/11 (0%) 0 0/5 (0%) 0
Clear Cell Papillary RCC 0/5 (0%) 0 0 N/A
MTSCC 0/1 (0%) 0 0 N/A
Collecting Duct Carcinoma 0/3 (0%) 0 0 N/A
Translocation RCC 0/4 (0%) 0 0 N/A
RCC, unclassified 0/6 (0%) 1.3 0/7 (0%) 0.3